Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact
Login Book a demo
Psynova Neurotech logo — Pioneering the future of mental health through innovative bi...

Psynova Neurotech

Pioneering the future of mental health through innovative biomarker development.

Founded 2005 Grant Total: $5.00M Biotechnology

General Information

Company Name Psynova Neurotech
Founded Year 2005
Industries Biotechnology
Funding Stage Grant
Social

BounceWatch is an independent company data service, not affiliated with Psynova Neurotech. To contact Psynova Neurotech, visit psynova-neurotech.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does Psynova Neurotech compare?

A PDF of Psynova Neurotech and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting Psynova Neurotech soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About Psynova Neurotech

Psynova Neurotech is a biotechnology startup founded in 2005 that aims to revolutionize the field of mental health through innovative biomarker development. The company's slogan, "Pioneering the future of mental health through innovative biomarker development," encapsulates its commitment to pushing the boundaries of mental health diagnosis and treatment. Psynova Neurotech's exclusive focus on the commercial development and exploitation of novel biomarkers for Neuropsychiatric and other mental illnesses positions it as a pioneering force in the biotechnology industry. The company's dedication to addressing critical gaps in mental health diagnostics and treatment is commendable. In July 2009, Psynova Neurotech secured a grant investment of €2.75M from the European Commission, highlighting recognition and support from a prominent institution. This backing serves as a testament to the company's potential and the significance of its innovative approach. Overall, Psynova Neurotech's strategic focus, groundbreaking work in biomarker development, and support from influential investors such as the European Commission position it as a promising player in the biotechnology landscape, with the potential to make substantial contributions to the future of mental health.

Business keywords: biomarker development, neurotech, mental health, neuropsychiatric illnesses, biomarkers, commercial development, exploitation, mental illnesses, biomarker, commercialization, innovation

Funding Rounds & Investors (2)

View All
Funding Stage Amount Investors Lead Investors Date
Grant €2.75M 1
European Commission
15 Jul 2009
Venture Round £2.25M 2
Porton Group
Porton Group, University of Cambridge Enterprise
16 Mar 2006

Psynova Neurotech Alternatives & Competitors

View All Alternatives
Psynova Neurotech vs
Gate Neurosciences
Gate Neurosciences United States

Brain Health, Reimagined

Venture round
15 employees
Biotechnology, Health Care
Psynova Neurotech vs
Psyomics
Psyomics United Kingdom

Technology to help people get the mental health support they need sooner.

Venture round
23 employees
Biotechnology, Education
Psynova Neurotech vs
Spiritus Bioscience
Spiritus Bioscience

Improve existing strategies of drug delivery for some of the most pressing mental health issues of o...

Venture round
3 employees
Biotechnology, Health and Wellness
View all alternatives

FAQ About Psynova Neurotech

Pioneering the future of mental health through innovative biomarker development.
Psynova Neurotech was founded in 2005.
Psynova Neurotech operates in Biotechnology. Its work centres on biomarker development, neurotech, mental health and neuropsychiatric illnesses.
Psynova Neurotech has completed 2 funding rounds, raising a total of $5.00M. The latest funding stage is Grant.
Top alternatives and competitors to Psynova Neurotech include Gate Neurosciences, Psyomics, Spiritus Bioscience, Cotherix, Neumora. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Psynova Neurotech and Gate Neurosciences are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for Psynova Neurotech, https://bouncewatch.com/company/psynova-neurotech, updated 10 October 2024. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes